Omadacycline
Omadacycline is a modern tetracycline-class antibiotic used to treat adults with community-acquired bacterial pneumonia (CABP) and acute bacterial skin and skin-structure infections (ABSSSI) caused by susceptible organisms. It works by binding to the bacterial 30S ribosomal subunit, inhibiting protein synthesis and preventing bacterial growth. Omadacycline is available as oral tablets and an intravenous formulation, with treatment regimens depending on the infection and route of administration. Common side effects include nausea, vomiting, diarrhoea, and headache. Important precautions include possible photosensitivity, effects on developing teeth and bones, and rare hypersensitivity reactions; intravenous administration may also cause infusion-site reactions. It should be used under medical supervision, with attention to administration instructions, pregnancy considerations, and appropriate antibiotic stewardship.
Omadacycline was historically used as a respiratory medicine for the symptomatic management of certain respiratory conditions. Its former uses included:
is okay
The import of medicines into India is regulated by the Central Drugs Standard Control Organisation (CDSCO) under the Drugs and Cosmetics Act, 1940, and the Drugs and Cosmetics Rules, 1945. The regulatory requirements depend on whether the product is an active pharmaceutical ingredient (API), a finished formulation, or an unapproved medicine intended for an individual patient's treatment.
Primeera Healthcare Private Limited can provide import coordination and pharmaceutical documentation assistance for Omadacycline, subject to confirmation of its current regulatory status and eligibility for import into India.
The export of Omadacycline from India is subject to applicable requirements under the Drugs and Cosmetics Act, 1940, the Drugs and Cosmetics Rules, 1945, and relevant export, customs, and destination-country regulations. Documentation requirements depend on whether the product is an active pharmaceutical ingredient (API), a finished pharmaceutical formulation, or a medicine intended for a specific market. Export eligibility and destination-country requirements must be verified before shipment.
Primeera Healthcare Private Limited can provide pharmaceutical export documentation assistance, regulatory coordination, and shipping support for Omadacycline, subject to confirmation of its export eligibility under applicable Indian regulations and the import requirements of the destination country.
If you have any questions or need any help, contact our Support Team. We will get in touch with you within 24 hours from Monday to Friday between 9:00 and 10:00 CET.
All Trademarks and Brands that appear on the website belong to their respective owners. Primeera Healthcare does not lay any claim on them; we only provide information.
